Cyclopharm Limited (CYC.AX)
AUD 1.52
(-5.31%)
AUD 1.52
(-5.31%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -7.49 Million AUD | 53.03% |
| 2022 | -15.96 Million AUD | 35.47% |
| 2021 | -24.73 Million AUD | -973.51% |
| 2020 | 2.83 Million AUD | 136.6% |
| 2019 | -7.73 Million AUD | -34.94% |
| 2018 | -5.73 Million AUD | 32.65% |
| 2017 | -8.51 Million AUD | -85.48% |
| 2016 | -4.59 Million AUD | 26.52% |
| 2015 | -6.24 Million AUD | -106.69% |
| 2014 | -3.02 Million AUD | -352.66% |
| 2013 | 1.19 Million AUD | -6.15% |
| 2012 | 1.27 Million AUD | -54.16% |
| 2011 | 2.78 Million AUD | -39.04% |
| 2010 | 4.56 Million AUD | 342.75% |
| 2009 | -1.87 Million AUD | -27.56% |
| 2008 | -1.47 Million AUD | -579.88% |
| 2007 | 306.95 Thousand AUD | 0.0% |
| 2005 | -1.33 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -21.99 Million AUD | 0.0% |
| 2023 Q4 | -7.49 Million AUD | 0.0% |
| 2023 Q2 | -13.84 Million AUD | 0.0% |
| 2023 FY | -7.49 Million AUD | 53.03% |
| 2022 Q4 | -15.96 Million AUD | 0.0% |
| 2022 Q2 | -22.09 Million AUD | 0.0% |
| 2022 FY | -15.96 Million AUD | 35.47% |
| 2021 Q2 | -27.05 Million AUD | 0.0% |
| 2021 FY | -24.73 Million AUD | -973.51% |
| 2021 Q4 | -24.73 Million AUD | 0.0% |
| 2020 FY | 2.83 Million AUD | 136.6% |
| 2020 Q4 | 2.83 Million AUD | 0.0% |
| 2020 Q2 | -3.22 Million AUD | 0.0% |
| 2019 Q2 | 320.11 Thousand AUD | 0.0% |
| 2019 Q4 | -7.73 Million AUD | 0.0% |
| 2019 FY | -7.73 Million AUD | -34.94% |
| 2018 FY | -5.73 Million AUD | 32.65% |
| 2018 Q2 | -7.46 Million AUD | 0.0% |
| 2018 Q4 | -5.73 Million AUD | 0.0% |
| 2017 Q2 | -10.61 Million AUD | 0.0% |
| 2017 FY | -8.51 Million AUD | -85.48% |
| 2017 Q4 | -8.51 Million AUD | 0.0% |
| 2016 FY | -4.59 Million AUD | 26.52% |
| 2016 Q4 | -4.59 Million AUD | 0.0% |
| 2016 Q2 | -6.81 Million AUD | 0.0% |
| 2015 FY | -6.24 Million AUD | -106.69% |
| 2015 Q4 | -6.24 Million AUD | 0.0% |
| 2015 Q2 | -3.39 Million AUD | 0.0% |
| 2014 Q4 | -3.02 Million AUD | 0.0% |
| 2014 Q2 | 149.32 Thousand AUD | 0.0% |
| 2014 FY | -3.02 Million AUD | -352.66% |
| 2013 FY | 1.19 Million AUD | -6.15% |
| 2013 Q2 | 1.81 Million AUD | 0.0% |
| 2013 Q4 | 1.19 Million AUD | 0.0% |
| 2012 FY | 1.27 Million AUD | -54.16% |
| 2012 Q4 | 1.27 Million AUD | 0.0% |
| 2011 FY | 2.78 Million AUD | -39.04% |
| 2011 Q4 | 2.78 Million AUD | 0.0% |
| 2010 Q4 | 4.56 Million AUD | 0.0% |
| 2010 FY | 4.56 Million AUD | 342.75% |
| 2009 FY | -1.87 Million AUD | -27.56% |
| 2009 Q4 | -1.87 Million AUD | 0.0% |
| 2008 FY | -1.47 Million AUD | -579.88% |
| 2008 Q4 | -1.47 Million AUD | 0.0% |
| 2007 Q4 | 306.95 Thousand AUD | 0.0% |
| 2007 FY | 306.95 Thousand AUD | 0.0% |
| 2005 FY | -1.33 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 70.575% |
| Adherium Limited | -6.1 Million AUD | -22.849% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -100.129% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -108.117% |
| Anteris Technologies Ltd | -28.49 Million AUD | 73.686% |
| Control Bionics Limited | -19.02 Thousand AUD | -39323.441% |
| CardieX Limited | 2.74 Million AUD | 373.061% |
| Compumedics Limited | 5.08 Million AUD | 247.417% |
| Cochlear Limited | -269.9 Million AUD | 97.222% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 1173.463% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 52.239% |
| Nova Eye Medical Limited | -2.8 Million AUD | -167.635% |
| HeraMED Limited | -799.34 Thousand AUD | -838.155% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 151.779% |
| ImpediMed Limited | -23.48 Million AUD | 68.074% |
| InhaleRx Limited | -155.54 Thousand AUD | -4721.226% |
| LBT Innovations Limited | -604 Thousand AUD | -1141.577% |
| Micro-X Limited | 826.99 Thousand AUD | 1006.788% |
| Neurotech International Limited | -2.11 Million AUD | -255.328% |
| OncoSil Medical Limited | -4.43 Million AUD | -69.253% |
| PolyNovo Limited | -30.52 Million AUD | 75.434% |
| Respiri Limited | 413.68 Thousand AUD | 1912.745% |
| SomnoMed Limited | -15.16 Million AUD | 50.543% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -41.388% |
| Uscom Limited | -1.53 Million AUD | -389.936% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -83.669% |